February 20, 2025 -EverBridge group and Kaneka Medix Corporation (“Kaneka”or “Kaneka group” ) announced that they have reached a distribution cooperation for Kaneka Group's i-ED embolization coils. According to the terms of the agreement, EverBridge will become the distributor of Kaneka Group's i-ED embolization coils in the...

EverBridge Group Showcases at OCIN 2024 From October 24 to 27, 2024, the Oriental Conference on Cerebrovascular Diseases 2024 (OCIN 2024) and the Academic Annual Meeting of the Stroke Branch of the Shanghai Medical Association successfully concluded in Shanghai, China. EverBridge Group's neuroscience business unit presented...

On September 4, 2024, the strategic cooperation meeting between EverBridge Group and Beijing Guanqiao Medical Technology Co., Ltd. was successfully held in Shanghai, marking the beginning of a new chapter in their collaboration in the field of pulmonary vascular intervention. This partnership between EverBridge Group and...

From July 18 to 21, 2024, the 17th China Southern Endovascular Congress (SEC 2024) was held in Guangzhou as scheduled. The conference brought together renowned doctors, professors, and experts in the field of vascular medicine from both China and abroad, engaging in in-depth discussions on clinical...

On June 19, 2024, EverBridge Group participated in the Florida International Medical Equipment Exhibition (FIME) in the United States with multiple product lines, further expanding its overseas "circle of friends", achieving several international cooperation deals, and ultimately concluding the event successfully. As a highly prestigious medical...

On Jun 1st, 2024, EverBridge (Shanghai) Medical Co., Ltd., ("EverBridge Group") and Pulmonx Corporation (" Pulmonx ", NASDAQ: LUNG) announced a strategic collaboration. Under the terms of the agreement, EverBridge Group will be responsible for the sales and promotion of the Zephyr Endobronchial Valve, Chartis Pulmonary...